SOPHiA GENETICS SA (Nasdaq: SOPH), today announced that the Company has published its first Environmental, Social and Governance Impact Summary. The ESG Impact Summary highlights the Company’s policies, ongoing practices, and recent initiatives across a range of areas including innovation and access, protecting patient data, empowering its people, as well as other key priority areas. The ESG Impact Summary is available on SOPHiAGENETICS.COM, in the Investor Relations section.

“We are thrilled to be taking the first steps in SOPHiA GENETICS’ ESG journey. We place patient care at the heart of all our decisions. Our success is deeply rooted in our core values and the positive impact we have in the ESG areas across all levels of the organization. This is critical to our mission of creating a wiser and more sustainable healthcare system,” said Dr. Jurgi Camblong, Co-Founder and CEO at SOPHiA GENETICS.

Source: SOPHiA GENETICS

See related articles: Daniel Benjamens, Michael Boni, Andrzej Ryz, Frank Ricotta, and Alex Cahana Discuss Blockchain in Healthcare at Blockchain for Europe Summit | ESG News – EU Parliament, Artemis DNA, Genetic and Diagnostic Testing Company, Expands Services Internationally to Vietnam, Creating a better plant-protein ingredient,